High risk of cardiovascular diseases after diagnosis of multiple sclerosis
We recommend careful surveillance and preventive CVDs measures among MS patients, particularly among the women.
CAMPATH (Alemtuzumab) improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis
Alemtuzumab was associated with a greater chance of improved contrast sensitivity in patients with RRMS and may delay the worsening of visual function.
Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen Idec's Tecfidera to be a Breakthrough in the Treatment of Multiple Sclerosis
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis
Symptom overlap in anxiety and multiple sclerosis
Cerebral white matter blood flow and energy metabolism in multiple sclerosis
Our results suggest that in MS patients there is no relationship between reduced CBF in NAWM and impaired axonal mitochondrial metabolism or astrocytic PCr metabolism.
Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance
This study aimed to determine the relation between real-life arm performance and clinical tests in MS. Real-life arm performance is decreased in wheelchair-bound MS patients and can be best predicted by measures on ‘body functions & structures’ level and fine motor control.
Retinal nerve fiber layer thickness in benign multiple sclerosis
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI
Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes
Childhood body mass index and multiple sclerosis risk: a long-term cohort study
Obesity in late adolescence has been associated with an increased risk of multiple sclerosis (MS); however, it is not known if body size in childhood is associated with MS risk. Having a high BMI in early life is a risk factor for MS, but the mechanisms underlying the association remain to be elucidated.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)
Definite diagnosis of inflammatory demyelinating disease (multiple sclerosis (MS) and neuromyelitis optica (NMO)) may require time, but early treatment offers the opportunity to maximize patient outcomes.
